Exelixis
The primary objective of this long-term extension study is to allow continued access to study treatment for eligible participants who are deriving clinical benefit in an Exelixis-sponsored study who do not have access to treatment locally.
Key Inclusion Criteria: * Eligible to continue receiving the study treatment in the parent study (that is, has not met parent study discontinuation/withdrawal criteria). * Continuing to derive clinical benefit from the study treatment at the time of transition from the parent study as assessed by the investigator. * Able to comply with the long-term extension study protocol as determined by the investigator. * Able to receive the first dose of study treatment in this extension study within the specified treatment interruption window allowed by the parent study. Key Exclusion Criteria: * Mee…
Administered as specified in the parent study.
Administered as specified in the parent study.
Administered as specified in the parent study.
Administered as specified in the parent study.
Administered as specified in the parent study.
Administered as specified in the parent study.
Administered as specified in the parent study.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.